Cellectis SA (CLLS)
4.47
-0.15
(-3.25%)
USD |
NASDAQ |
Dec 09, 10:04
Cellectis Profit Margin (Quarterly): 1.67% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| EDAP TMS SA | -36.13% |
| DBV Technologies SA | -- |
| Genfit SA | -- |
| Ascendis Pharma A/S | -28.55% |
| Akari Therapeutics Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -31.08% |
| Return on Assets | -9.65% |
| Return on Invested Capital | -15.69% |
| Gross Profit Margin (Quarterly) | 85.76% |
| Operating Margin (Quarterly) | 16.76% |
| Return on Net Operating Assets | -41.54% |